| Psoriasis References |
|
1. Merck Manual of Diagnosis. Merck Research Laboratories, Whitehouse Station, NY, 1999: 512-514.
2. Voorhees J and Duell E. Imbalanced Cyclic AMP-Cyclic GMP Levels in Psoriasis. Adv Cyc Nucl Res 1975;5:755-757.
3. Murray MT and Pizzorno JE. Encyclopedia of Natural Medicine, 2nd Ed. Prima Publishing, Rocklin, CA 1998:764-765
4. Seville RH. Stress and Psoriasis: the Importance of Insight and Empathy in Prognosis. J Amer Acad Derm 1989;20(1):97-100.
5. Muller-Limmroth W, FRohlich HH. Effect of various phytotherapeutic expectorants on mucociliary transport. Fortschritte der Medizin 1980; 98(3):95-101.
6. Bittner SB, et al. A double blind randomized placebo controlled trial of fish oil in psoriasis. Lancet 1988;1:378-380.
7. Kojima T, et al. Long-term administration of highly purified eicosapentaenoic acid provides improvement in psoriasis. Dermatoligica 1991;182:225-230.
8. Nieboer C, et al. Systemic therapy with fumaric acid derivatives: new possibilities in the treatment of psoriasis. J Am Acad Dermatol 1989;20:601-608.
9. Ellis CN, et al. A double-blind evaluation of topical capsaicin in pruritic psoriasis. J Am Acad Dermatol 1993;29:438-442.
10. Perez A, et al. Efficacy and safety of topical calcitriol (1,25-dihydroxycholecalciferol) for the treatment of psoriasis. Br J Dermatol 1996;134:238-246.
11. S Takamoto, et al. Effect of 1-Alpha-Hydroxycholecalciferol on Psoriasis Vulgaris: A Pilot study. Calcif Tissue Int 1986;39:360-364.
12. Evans FQ. The rational Use of Glycyrrhetinic Acid in Dermatology. Br J Clin Pract 1958;12:269-279.
13. Syed TA, et al. Management of psoriasis with Aloe vera extract in a hydrophilic cream: a placebo-controlled, double-blind study. Trop Med Int Health. 1996;Aug 1(4):505-9.
|